Compounding pharmacies in Georgia

By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified Sep 22, 2026

The Georgia State Board of Pharmacy regulates compounding pharmacies in Georgia. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

Georgia at a glance

Pharmacy regulator: Georgia State Board of Pharmacy
503A framework: Follows the federal 503A framework
Telehealth prescribing: Regulatory: Telehealth allowed
Asynchronous prescribing: Regulatory: Async not allowed
Compounded GLP-1 access: Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving Georgia

No verified compounding pharmacies serving Georgia are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in Georgia

The Georgia State Board of Pharmacy regulates pharmacies under O.C.G.A. Title 26, Chapter 4 and Board rules in chapter 480 of the Rules and Regulations of the State of Georgia. Georgia has no separate state bulks list; Board rule 480-11-.02(6) lets pharmacists compound from bulk substances that meet an applicable USP-NF monograph, are components of FDA-approved drugs, or are otherwise approved by FDA, and federal 503A limits apply on top of that. Since July 1, 2013, O.C.G.A. 26-4-114.1 requires any person, pharmacy, or facility outside Georgia that ships, mails, or delivers dispensed drugs into Georgia to hold a Georgia nonresident pharmacy permit; under Board rule 480-6-.02 the pharmacist in charge must be licensed in the pharmacy's home state, and a nonresident pharmacy that performs sterile or non-sterile compounding must submit an inspection report with its application. Compounding standards are in Board rule chapter 480-11 (Pharmaceutical Compounding): rule 480-11-.02(8) makes all sterile compounded preparations subject to USP chapter 797 and non-sterile preparations subject to USP chapter 795, rule 480-11-.02(12)(b) bars compounding essentially copies of commercially available products except for a prescriber-ordered change for an individual patient, unavailability, or a drug-shortage listing, rule 480-11-.04(3) sets the facility and equipment requirements for sterile parenteral compounding, and rule 480-11-.09 requires a quality assurance program for sterile preparations. [1] [4] [5] [6] [8]

Compounded GLP-1 access in Georgia

The practical Georgia barrier is the prescription itself: many national asynchronous GLP-1 programs must add a video exam or require a prior in-person exam for Georgia patients to satisfy rule 360-3-.07. [2] [3] [11]

Research use only sellers in Georgia

Only Georgia-licensed pharmacies and permitted nonresident pharmacies may dispense prescription drugs to Georgia patients. "Research use only" peptides sold for human injection are unapproved new drugs under federal law regardless of labeling and are not dispensed by a pharmacist. Georgia law also bars the sale directly: O.C.G.A. 26-3-10 provides that no person shall sell, deliver, offer for sale, hold for sale, or give away any new drug unless an application for it has become effective under section 505 of the federal act (or, for a drug not subject to the federal act, a state application has been filed with the State Board of Pharmacy), with an exemption only for drugs intended solely for investigational use by qualified experts and plainly labeled "For investigational use only." [4] [7] [12]

Georgia notes on specific peptides

Semaglutide: Available branded by prescription, but a first telemedicine prescription in Georgia generally requires a prior in-person exam or an exam with technology equal to one under rule 360-3-.07. Compounded semaglutide is limited to documented patient-specific needs since the 503A grace period ended April 22, 2025. [2] [11]
Tirzepatide: Available branded by prescription under the same Georgia telemedicine exam rule. Compounded tirzepatide is limited to documented patient-specific needs since the 503A grace period ended February 18, 2025, and must come from a Georgia or permitted nonresident pharmacy. [2] [4] [11]

How to check a compounding pharmacy in Georgia

Search the Georgia State Board of Pharmacy license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Georgia requires before it ships to you. [1] [4] [5] [6] [8]
Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Georgia. [4] [7] [12]

Common questions in Georgia

What does an out-of-state pharmacy need to ship compounded peptides to Georgia?

A Georgia nonresident pharmacy permit under O.C.G.A. 26-4-114.1. Under Board rule 480-6-.02, a nonresident pharmacy that compounds must also submit an inspection report when it applies. Verify the permit on the Georgia Board of Pharmacy license lookup. [4] [5]

Can a Georgia pharmacy compound BPC-157?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [9] [10]

All peptide legal questions for Georgia